1. Market Research
  2. > Healthcare
  3. > Pathology Market Trends
  4. > Generics in Brazil

Generics in Brazil

  • January 2016
  • -
  • MarketLine
  • -
  • 31 pages

Introduction

Generics in Brazil industry profile provides top-line qualitative and quantitative summary information including: market size (value and volume 2011-15, and forecast to 2020). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market. Essential resource for top-line data and analysis covering the Brazil generics market. Includes market size data, textual and graphical analysis of market growth trends, leading companies and macroeconomic information.

Highlights

- For the purposes of this profile, a generic is defined as a copy of an ethical (prescription) drug formerly protected by patents that have now expired. Both unbranded generics and all branded generics are included. However, off-patent drugs that continue to be offered by the original manufacturer under the original name, and which form part of the 'generic-eligible' market, are not included.

- The Brazilian generics market is expected to generate total revenues of $6.9bn in 2015, representing a compound annual growth rate (CAGR) of 16.6% between 2011 and 2015.

- Market consumption volume is forecast to reach a total of 28.2 % of total pharma volume in 2015.

- The sale of generic drugs is expected to outstrip the larger market, so much so that generics are expected to have a market share of nearly half by 2020.

Features

- Save time carrying out entry-level research by identifying the size, growth, and leading players in the generics market in Brazil

- Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the generics market in Brazil

- Leading company profiles reveal details of key generics market players’ global operations and financial performance

- Add weight to presentations and pitches by understanding the future growth prospects of the Brazil generics market with five year forecasts by both value and volume

- Macroeconomic indicators provide insight into general trends within the Brazil economy

Key Questions Answered

- What was the size of the Brazil generics market by value in 2015?

- What will be the size of the Brazil generics market in 2020?

- What factors are affecting the strength of competition in the Brazil generics market?

- How has the market performed over the last five years?

- How large is Brazil’s generics market in relation to its regional counterparts?

Table Of Contents

Generics in Brazil
TABLE OF CONTENTS
Executive Summary 2
Market value 2
Market value forecast 2
Market volume 2
Market volume forecast 2
Geography segmentation 2
Market rivalry 2
Market Overview 7
Market definition 7
Market analysis 7
Market Data 9
Market value 9
Market volume 10
Market Segmentation 11
Geography segmentation 11
Market Outlook 12
Market value forecast 12
Market volume forecast 13
Five Forces Analysis 14
Summary 14
Buyer power 15
Supplier power 16
New entrants 17
Threat of substitutes 18
Degree of rivalry 19
Leading Companies 20
O Ache Laboratórios Farmacêuticos S.A. 20
EMS Sigma Pharma 21
Eurofarma Laboratórios Ltda 22
Sanofi SA 23
Macroeconomic Indicators 26
Country Data 26
Methodology 28
Industry associations 29
Related MarketLine research 29
Appendix 30
About MarketLine 30

List of Tables
Table 1: Brazil generics market value: $ billion, 2011-15(e)
Table 2: Brazil generics market volume: % of total pharma volume, 2011-15(e)
Table 3: Brazil generics market geography segmentation: $ billion, 2015(e)
Table 4: Brazil generics market value forecast: $ billion, 2015-20
Table 5: Brazil generics market volume forecast: % of total pharma volume, 2015-20
Table 6: O Ache Laboratórios Farmacêuticos S.A.: key facts
Table 7: EMS Sigma Pharma: key facts
Table 8: Eurofarma Laboratórios Ltda: key facts
Table 9: Sanofi SA: key facts
Table 10: Sanofi SA: key financials ($)
Table 11: Sanofi SA: key financials (€)
Table 12: Sanofi SA: key financial ratios
Table 13: Brazil size of population (million), 2011-15
Table 14: Brazil gdp (constant 2005 prices, $ billion), 2011-15
Table 15: Brazil gdp (current prices, $ billion), 2011-15
Table 16: Brazil inflation, 2011-15
Table 17: Brazil consumer price index (absolute), 2011-15
Table 18: Brazil exchange rate, 2011-15

List of Figures
Figure 1: Brazil generics market value: $ billion, 2011-15(e)
Figure 2: Brazil generics market volume: % of total pharma volume, 2011-15(e)
Figure 3: Brazil generics market geography segmentation: % share, by value, 2015(e)
Figure 4: Brazil generics market value forecast: $ billion, 2015-20
Figure 5: Brazil generics market volume forecast: % of total pharma volume, 2015-20
Figure 6: Forces driving competition in the generics market in Brazil, 2015
Figure 7: Drivers of buyer power in the generics market in Brazil, 2015
Figure 8: Drivers of supplier power in the generics market in Brazil, 2015
Figure 9: Factors influencing the likelihood of new entrants in the generics market in Brazil, 2015
Figure 10: Factors influencing the threat of substitutes in the generics market in Brazil, 2015
Figure 11: Drivers of degree of rivalry in the generics market in Brazil, 2015
Figure 12: Sanofi SA: revenues and profitability
Figure 13: Sanofi SA: assets and liabilities

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
2016 Virology and Bacteriology Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales and Segment Forecasts for 100 Microbiology Tests, Technology Trends, Opportunities for Suppliers

2016 Virology and Bacteriology Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales and Segment Forecasts for 100 Microbiology Tests, Technology Trends, Opportunities for Suppliers

  • $ 54501
  • Industry report
  • October 2016
  • by Venture Planning Group

This unique 33-country survey from VPGMarketResearch.com contains over 2,100 pages, 875 tables and provides data and analysis not available from any other published source. The survey is designed to assist ...

2016 Infectious Disease Testing Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Microbiology Tests, Technology Trends, Opportunities for Suppliers

2016 Infectious Disease Testing Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Microbiology Tests, Technology Trends, Opportunities for Suppliers

  • $ 54501
  • Industry report
  • October 2016
  • by Venture Planning Group

This unique 33-country survey from VPGMarketResearch.com contains over 2,100 pages, 875 tables and provides data and analysis not available from any other published source. The survey is designed to assist ...

2016 Microbiology Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Molecular Diagnostic, Microbial Identification, Antibiotic Susceptibility, Blood Culture, Urine Screening, and Immunodiagnostic Tests

2016 Microbiology Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Molecular Diagnostic, Microbial Identification, Antibiotic Susceptibility, Blood Culture, Urine Screening, and Immunodiagnostic Tests

  • $ 47500
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 33-country survey from VPGMarketResearch.com contains over 1,000 pages and 550 tables, and provides granular data and analysis not available from any other published source. The survey is designed ...


ref:plp2016

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.